Related Experiment Video
Updated: Jul 1, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
[Primary Generalized Glucocorticoid Resistance: a case report]
I I Larina1, N V Makazan1, K V Ivashchenko1
1Endocrinology Research Centre.
Abstract:
Primary glucocorticoid resistance (OMIM 615962) is a rare endocrinologic condition caused by resistance of the human glucocorticoid receptor (hGR) to glucocorticoids (GR) and characterised by general or partial insensitivity of target organs to GK. Compensatory activation of hypothalamic-pituitary-andrenal axis results in development of a various pathological conditions caused by overstimulation of adrenal glands. Clinical spectrum may range from asymptomatic cases to severe cases of mineralocorticoid and/or androgen excess. At present time, primary generalized glucocorticoid resistance has been exclusively associated with defects in the NR3C1 gene. Here, we present a case report of an adolescent patient with clinical presentation of glucocorticoid resistance confirmed by detailed endocrinologic evaluation but no confirmed mutations in the NR3C1 gene.
Insights
Primary glucocorticoid resistance, a condition of insensitivity to glucocorticoids (GC), typically involves NR3C1 gene defects. This case highlights an adolescent with GC resistance despite no NR3C1 mutations, expanding the known genetic landscape of this rare disorder.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Primary glucocorticoid resistance (PGR) is a rare disorder characterized by target organ insensitivity to glucocorticoids (GC).
- It stems from defects in the human glucocorticoid receptor (hGR), leading to compensatory hypothalamic-pituitary-adrenal (HPA) axis activation.
- Clinical manifestations vary, from asymptomatic cases to mineralocorticoid and/or androgen excess.
Observation:
- This report details an adolescent patient presenting with clinical signs of glucocorticoid resistance.
- Endocrinologic evaluations confirmed the patient's insensitivity to glucocorticoids.
- Genetic analysis did not reveal mutations in the NR3C1 gene, the commonly associated gene for PGR.
Findings:
- The patient exhibited features of glucocorticoid resistance.
- No mutations were identified in the NR3C1 gene, challenging the established genetic basis for PGR.
- This suggests potential novel genetic or epigenetic factors contributing to glucocorticoid resistance.
Implications:
- The findings broaden the understanding of the genetic heterogeneity of primary glucocorticoid resistance.
- This case underscores the need for comprehensive genetic screening beyond NR3C1 in suspected PGR cases.
- Further research is warranted to identify alternative genetic or molecular mechanisms underlying this rare endocrinopathy.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Hypoglycemia and Glucagon
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
GPCR Desensitization
Phase II Reactions: Glucuronidation

